Valuation NFL Biosciences

Stocks

Market Closed - Euronext Paris 18:55:00 11/09/2026 +03			5-day change	1st Jan Change
0.8400 ^EUR	-2.33%		-2.33%	-28.69%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025
Market Cap ¹	12.56	10.29	11.67	19.12	14.93
Change	-	-18.12%	13.49%	63.78%	-21.92%
Enterprise Value (EV) ¹	9.443	9.155	9.206	17.05	13.31
Change	-	-3.05%	0.56%	85.17%	-21.93%
P/E	-12.8x	-4.21x	-3.14x	-9.56x	-4.62x
PBR	3.82x	12.2x	33.6x	19.8x	48.8x
PEG	-	-0x	1.88x	0.2x	-0.2x
Capitalization / Revenue	322,130x	467,546x	58.4x	415,647x	79,404x
EV / Revenue	242,134x	416,129x	46x	370,592x	70,790x
EV / EBITDA	-11x	-3.02x	-2.21x	-6.26x	-3.51x
EV / EBIT	-10.5x	-2.97x	-2.18x	-6.11x	-3.44x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-0.1869	-0.4668	-0.459	-0.206	-0.255
Distribution rate	-	-	-	-	-
Net sales ¹	0.000039	0.000022	0.2	0.000046	0.000188
EBITDA ¹	-0.8584	-3.031	-4.174	-2.723	-3.786
EBIT ¹	-0.9019	-3.083	-4.23	-2.79	-3.873
Net income ¹	-0.9782	-2.443	-3.745	-2.081	-3.318
Net Debt ¹	-3.12	-1.131	-2.467	-2.073	-1.619
Reference price ²	2.4000	1.9650	1.4400	1.9700	1.1780
Nbr of stocks (in thousands)	5,235	5,235	8,107	9,705	12,672
Announcement Date	4/29/22 A	4/28/23 A	4/14/25 A	4/14/25 A	4/27/26 A

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NFL BIOSCIENCES	-	-	-	-	12.67M
WUXI APPTEC CO., LTD.	20.07x	7.08x	14.22x	1.48%	68.24B
ARGENX SE	32.07x	9.28x	44.74x	0.04%	62.23B
INSMED INCORPORATED	-77.91x	15.04x	-72.53x	-.--%	27.8B
WUXI BIOLOGICS (CAYMAN) INC.	28.78x	6.1x	15.83x	-.--%	24.86B
BIONTECH SE	-14.55x	5.23x	-6.58x	-.--%	24.22B
GENMAB A/S	26.34x	4.96x	16.5x	-.--%	19.36B
PHARMAESSENTIA CORPORATION	49.79x	18.37x	37.27x	0.3%	17.28B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1249.7x	36.02x	786.01x	-.--%	14.46B
EXELIXIS, INC.	17.74x	5.28x	12.34x	-.--%	14.23B
Average	148.00x	11.93x	94.20x	0.2%	27.27B
Weighted average by Cap.	77.96x	10.15x	53.10x	0.4%